These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3623734

  • 1. Comparison of sustained release verapamil and hydrochlorothiazide in hypertension--effect on blood pressure and metabolic variables.
    Lehtonen A, Gordin A, Salo H.
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):301-5. PubMed ID: 3623734
    [Abstract] [Full Text] [Related]

  • 2. Metabolic parameters after changing from hydrochlorothiazide to verapamil treatment in hypertension.
    Lehtonen A, Gordin A.
    Eur J Clin Pharmacol; 1984 Jun; 27(2):153-7. PubMed ID: 6389153
    [Abstract] [Full Text] [Related]

  • 3. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 4. Concomitant considerations in long-term antihypertensive treatment.
    Holzgreve H, Middeke M.
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():11-8. PubMed ID: 2090833
    [Abstract] [Full Text] [Related]

  • 5. [Biochemical changes in hypertensive patients during a 1-year cross-over study of treatment with hydrochlorothiazide and propranolol].
    Bagatin J, Rumboldt Z, Polić S, Sardelić S, Ljutić D, Capkun V, Pivac N, Petrović P, Bojić L.
    Lijec Vjesn; 1996 Dec; 118(1-2):11-6. PubMed ID: 8759414
    [Abstract] [Full Text] [Related]

  • 6. Relation between low dose of hydrochlorothiazide, antihypertensive effect and adverse effects.
    Jounela AJ, Lilja M, Lumme J, Mörlin C, Hoyem A, Wessel-Aas T, Borrild NJ.
    Blood Press; 1994 Jul; 3(4):231-5. PubMed ID: 7994447
    [Abstract] [Full Text] [Related]

  • 7. Hydrochlorothiazide is not additive to verapamil in treating essential hypertension.
    Nicholson JP, Resnick LM, Laragh JH.
    Arch Intern Med; 1989 Jan; 149(1):125-8. PubMed ID: 2643413
    [Abstract] [Full Text] [Related]

  • 8. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 9. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O.
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [Abstract] [Full Text] [Related]

  • 10. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H, Distler A, Michaelis J, Philipp T, Wellek S.
    BMJ; 1989 Oct 07; 299(6704):881-6. PubMed ID: 2510877
    [Abstract] [Full Text] [Related]

  • 11. [Glycemia increases during treatment of hypertension. 13 years' experience in the treatment of middle-aged men, randomized for treatment with beta blockers and diuretics].
    Válek J, Válková L, Storková H.
    Cas Lek Cesk; 1996 May 29; 135(11):344-7. PubMed ID: 8706070
    [Abstract] [Full Text] [Related]

  • 12. Hydrochlorothiazide-amiloride versus hydrochlorothiazide alone for essential hypertension: effects on blood pressure and serum potassium level.
    Larochelle P, Logan AG.
    Can Med Assoc J; 1985 Apr 01; 132(7):801-5. PubMed ID: 3884122
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the effects of fixed combinations of sustained-release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertension.
    Cifková R, Nakov R, Novozámská E, Hejl Z, Petrzílková Z, Poledne R, Stávek P, Compagnone D.
    J Hum Hypertens; 2000 Jun 01; 14(6):347-54. PubMed ID: 10878692
    [Abstract] [Full Text] [Related]

  • 14. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Jun 01; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 15. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA, Chou TC, Lin KC.
    J Hum Hypertens; 1994 Apr 01; 8(4):273-8. PubMed ID: 8021907
    [Abstract] [Full Text] [Related]

  • 16. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B.
    Curr Med Res Opin; 2001 Apr 01; 17(1):8-17. PubMed ID: 11464450
    [Abstract] [Full Text] [Related]

  • 17. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
    Spence JD, Huff M, Barnett PA.
    Can J Clin Pharmacol; 2000 Apr 01; 7(1):32-7. PubMed ID: 10822211
    [Abstract] [Full Text] [Related]

  • 18. Prazosin improves atherogenic index and inhibits the deleterious effect of dihydrochlorothiazide in patients with essential hypertension.
    Farsang C, Péter M, Balás-Eltes A, Fehér J.
    J Cardiovasc Pharmacol; 1987 Apr 01; 10 Suppl 12():S240-3. PubMed ID: 2455187
    [Abstract] [Full Text] [Related]

  • 19. Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension.
    Frishman WH, Eisen G, Charlap S, Strom JA.
    J Clin Hypertens; 1987 Dec 01; 3(4):605-9. PubMed ID: 3134517
    [Abstract] [Full Text] [Related]

  • 20. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA, Hals O, Lauve O.
    J Clin Hypertens; 1986 Sep 01; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.